Abstract
INTRODUCTION
On a global scale, the incidence and associated mortality of infectious diseases has fallen steadily since the mid-1950s (Hinman, 1989) . Th is decline has been particularly noted for vaccine-preventable diseases, including diphtheria, pertussis, tetanus, poliomyelitis, measles, mumps and rubella (CDC, 1999) . In more recent times, immunisation helped 1 Th e authors have no confl icts of interest. Portions of this paper were presented at the Price of Health conference on August 13, 2016, in Dubrovnik, Croatia. eradicate smallpox by 1978 (Fenner, 1982) , eliminated endemic polio, rubella and measles in the Americas (PAHO, 2015 (PAHO, , 2016 , and virtually eliminated invasive Haemophilus infl uenzae type b infections in high-income countries (Peltola, 2000) . Th ese declines in mortality are especially evident in children. For instance, in a particularly careful analysis undertaken in the Netherlands, the years of life lost before 20 years of age fell steadily from the cohort of children born in 1903 to the cohort born in 1992 (van Wijhe et al., 2016) . Mortality declined most precipitously for diphtheria and pertussis, and the authors have calculated that there were 3,000 fewer deaths and 38,000 fewer years of life lost before age 20 from diphtheria, and 6,000 fewer deaths and 103,000 fewer years of life lost before age 20 from pertussis after the introduction of mass vaccination programmes for these agents in 1953 and 1954 respectively (van Wijhe et al., 2016 . Equally impressive was the rapid decline in Haemophilus infl uenzae type b. In the United States of America, for example, the incidence of invasive disease declined from a high of 25 cases per 100,000 children under 5 years of age in 1984 to almost 0 in 1997 (Adams et al., 1993; CDC, 1998) . Th is was due to the introduction of a single-dose polysaccharide vaccine in 1986 and then a multi-dose conjugate vaccine series in 1990. It has been estimated that mass vaccination against Haemophilus infl uenzae type b has saved 13,700 lives in the United States from 1994 to 2013 (CDC, 2014) . Despite the clear public health success of mass childhood immunisations, such programmes are not without their critics. In this paper we review the United States experience with mandatory childhood immunisations and one state's (California) experience with these programmes.
IMMUNISATION REQUIREMENTS FOR SCHOOL ENTRY, UNITED STATES
In the United States, public health law is primarily the province of state governments. Each state enacts its own set of public health laws, which can diff er from state to state. Federal public health law is largely restricted to issues of communicable disease control at national borders and regulation of interstate commerce, for instance, of drugs and diagnostic devices (Gostin and Wiley, 2016) . Th e federal government provides funding and technical assistance to states through agencies such as the Centers for Disease Control and Prevention in order to assist them in promoting public health in general and to control communicable diseases of public health signifi cance in particular. Th e responsibility of the states for public health derives from their duty to protect their citizens and have their origin in their police powers (Gostin and Wiley, 2016) . For communicable disease control, the states have the power to limit individual liberty in order to protect public health through interventions such as quarantine and isolation. Immunisation requirements are an extension of these duties and powers. But, as with many laws, there is a balance between protecting public health while preserving individual liberties and commerce to the greatest extent possible. Overriding all these considerations is the medical tenet of doing no harm (Gostin and Gostin, 2009 ).
Th ere is a long history of requiring citizens to be immunised in the United States (Cole, and Swendiman, 2014) . Th e fi rst school vaccination requirements were enacted in 1850 in Massachusetts to prevent smallpox. As early as 1905, the United States Supreme Court in Jacobsen versus Massachusetts rejected the argument that an individual could refuse to be vaccinated for smallpox because he knew best how to care for his own body (Parmet et al., 2005; Duff y, 1978) . Th is landmark decision and others that followed allowed states to enact laws and regulations that required children to be immunised for certain communicable disease prior to entering school, and by 1980, all states had such requirements (Hinman et al., 2002) . At the same time, almost all states allowed exemptions for medical contraindications or for philosophical or religious reasons. Figure 1 shows which states allowed for religious exemptions and religious or philosophical exemptions in 2015 (NCSL, 2016) . Only two states at that time, Mississippi and West Virginia, did not allow these exemptions. (Hinman et al., 2002) .
Th e United States has long recognised that there is a low background rate of severe adverse events following childhood immunisation that can lead to permanent harm. Along with individual rights, issues of avoiding potential harm are at the heart of the anti-vaccination movement (College of Physicians of Philadelphia, 2017). To remedy injuries that might have resulted from mandatory immunisation, the United States enacted the National Vaccine Compensation Act in 1986 (Smith, 1988) . Th e Act created a no-fault alternative system to the traditional tort system for immunisation-associated injuries. As a result, it was anticipated that the Act would help retain vaccine manufacturers on the market, assure an adequate supply of vaccines, and stabilise vaccine prices. Compensation is funded by a $0.75 excise tax on each of the covered vaccines (HRSA, 2017) . Th e claims process has fi ve steps (see Box 1) . When pre-specifi ed conditions, such as anaphylaxis, occur within defi ned time periods after immunisation, it is presumed that the vaccine was the cause unless proven otherwise, and the aff ected individual is eligible for compensation. Persons with injuries that are not pre-specifi ed are still eligible for compensation if they can prove that immunisation was the cause. Th ere were 3,521 claims fi led from 2006 to 2014, against a background of 2.5 billion doses administered (one claim for every 710,000 vaccines administered). Of these 3,521 claims, 2,248 (64%) received compensation. Since the programme began in 1988, the total amount awarded has been $3.4 billion for 4,804 compensated claims ($70,000 per claim).
Immunisation against up to nine pathogens is currently required for entering California schools, whether they be public or private, or to pre-schools and child care centres.
Immunisations required for kindergarten include poliomyelitis (4 doses), diphtheria and tetanus toxoids and pertussis vaccine (5 doses, as DTP, DTaP or DT), hepatitis B (3 doses), measles, rubella and mumps (2 doses of measles-containing vaccine), and varicella (1 dose) (Smith, 1988) . DTP can be administered as whole cell pertussis vaccine (P), which is no longer available in the United States, or acellular pertussis vaccine (aP). Children who have had adverse events after DTP or DTaP may complete their requirements with diphtheria and tetanus toxoids (DT). Additionally, children entering or advancing into seventh grade are required to have an additional dose of reduced diphtheria toxoid, tetanus toxoids and acellular pertussis vaccine (Dtap). Prior to 2016, California law allowed for two types of exemptions to these required immunisations: those based on medical reasons, such as immunosuppression, which could be either permanent or temporary, and those due to personal beliefs, whether religious or otherwise. Over the last 15 years, the proportion of children entering kindergarten in California who have had all their required immunisations has fallen from almost 93% to less than 91%. Th is decline was much more pronounced for children entering private schools, where coverage fell from 90% to 86% (Figure 2 ). In the autumn of 2015 of the 551,123 children entering kindergarten in California, 511,708 (92.9%) were reported as having received all their required immunisations, 24,424 (4.4%) had been admitted conditionally, meaning that they were still completing their requirements after past delays or had temporary medical exemptions, and 974 (0.2%) were overdue for their fi nal immunisation (HRSA, 2017 ). An additional 931 (0.2%) children had permanent medical exemptions, and 13,086 (2.4%) claimed personal belief exemptions.
THE PROBLEM WITH MEASLES
Measles is possibly the most infectious of childhood diseases. Spread in respiratory secretions, the measles virus can cause severe multiorgan system disease (Holzmann et al., 2016) . Young children who are exposed after the transplacental maternal antibody wanes are at particularly high risk of life-threatening sequelae, such as pneumonia and diarrhoea. Th us, infants and young children need to be immunised as soon as possible after maternal antibodies have disappeared; in the United States, the recommended age for measles immunisation is typically between 12 and 15 months of age (CDC, 2013) . Th e extreme contagiousness of measles is refl ected in an estimated 92-94% threshold herd immunity level necessary to interrupt transmission (Fine and Mulholland, 2008) . Failures either to achieve or sustain such levels of immunity are the main challenges with measles. If parents wait to immunise their children against measles until entering school at 5 years of age, the ensuing pool of non-immune children can sustain an epidemic transmission. Th is is what happened in California, and indeed throughout the Western Hemisphere, from 1988 to 1990 (Dales et al, 1993) . Once widespread transmission starts, measles spreads not only to unvaccinated people who had not been exposed to endemic measles in the years since the measles vaccine was introduced, but also to those whose immunisations have failed. Th e measles vaccine is ineff ective in about 5% of children immunised in the absence of a maternal antibody. If revaccinated, 95% of this 5% will become protected. To close this gap in immunity, in 1989 the US Advisory Committee on Immunization Practices recommended a second dose of measles vaccine (usually given with the mumps and rubella vaccine) for children right before entering school (National Vaccine Advisory Committee, 1991). Measles outbreaks can also occur in populations whose philosophical or religious beliefs preclude the attainment of herd immunity. In the wake of well-publicised allegations of autism occurring after receiving the MMR vaccine, which was sparked by a case series published in 1998 that was eventually retracted, MMR immunisation rates for young children in the United Kingdom fell well below the herd immunity threshold (ECDC, 2008 (Naus, et al. 2015; Glover, C. E., 2015) . Soon thereafter, an outbreak of measles following exposure at a southern California amusement park in December 2014 (CDC, 2015b) led to 125 cases in seven states, Canada and Mexico. Of the 110 cases that occurred in California, at least 60 (55%) were unvaccinated; 13 of these were too young to have received the measles vaccine at the recommended age, and at least 37 individuals had not been immunised against measles because of their families' personal beliefs. Th is highly-publicised amusement park outbreak led to the introduction in 2015 of California Senate Bill (SB) 277, which proposed to eliminate personal belief exemptions for new entrants into public and private schools and child care centres. Children who had received personal belief exemptions before 2016 could remain in school under their exemptions until they entered kindergarten (for the case of children in pre-school or child care centres) or 7 th grade (the grade children enter at 12 years old, for the case of children already in elementary school). Children receiving home-based instruction and those enrolled in independent study programmes outside of the classroom would no longer be subject to school immunisation requirements (California Legislative Information, 1995) . Advocates for the legislation included parents of a child with leukaemia concerned about potential exposures to vaccine-preventable diseases from unimmunised peers. Th e proponents noted that, despite the recent implementation of more stringent requirements for personal belief exemptions, in the autumn of 2014 only 92.6% of children entering kindergarten in California were reported as having had two MMRs (California Department of Public Health, 2016b), and 1199 (17%) kindergartens with 10 or more children reported more than 5% of pupils having personal belief exemptions to one or more required immunisations (California Department of Public Health, 2016a). SB 277 passed through both the California Assembly and the State Senate and was signed into law by Governor Jerry Brown on June 30, 2015. As a result, California became the third state in the United States to disallow personal belief exemptions to entering school. In his accompanying message, Governor Brown wrote: "Th e science is clear that vaccines dramatically protect children against a number of infectious and dangerous diseases. While it's true that no medical intervention is without risk, the evidence shows that immunization powerfully benefi ts and protects the community." (Brown, 2015) . Th us, in California at least, mandatory school immunisation requirements codifi ed in laws and regulations have been established as a prudent measure designed to protect both public health as well as individuals from infectious diseases.
PARALLELS TO OTHER COMMUNICABLE DISEASE CONTROL PROGRAMMES
In addition to childhood immunisation programmes, public health law also allows for a number of other proscriptive activities to protect public health and control the spread of both communicable and at least a few non-communicable diseases. Th ey generally fall into three groups -activities that support acquisition of data for public health and disease control eff orts, activities that involve mass administration of drugs, and activities that directly limit individual liberties in order to protect public health. Disease reporting and surveillance are long-standing public health activities. Th ey are needed to assist public health agencies in identifying individual cases of disease (for instance, individual cases of measles) as well as to understand the epidemiology of a disease and the on-going patterns of disease transmission (Declich and Carter, 1994) . Case reporting for individual cases of HIV was particularly controversial when there were few therapeutic options and prevention was limited to counselling and condom provision (Bayer and Fairchild, 2002) . Interestingly, this rapidly changed with the widespread availability of antiretroviral drugs (UNAIDS, 2014), changes in antiretroviral treatment guidelines to recommend treatment for everyone with HIV (WHO, 2015b) , and the discovery that antiretroviral therapy can virtually eliminate further sexual transmission of HIV (Rutherford and Anglemyer, 2016) . More recently data from case reporting has become the cornerstone of monitoring and evaluating national and worldwide progress to elimination of HIV (WHO, 2015a) . A second group of mandatory public health activities is mass screening, treatment or preventive supplementation, the latter including the addition of fl uoride to drinking water (Iheozor-Ejiofor et al., 2015) , iodide to salt or vitamins to cereal grains (Raitiainen et al., 2016) ; a prominent example is the decision to supplement cereal grains consumed by pregnant women with folic acid to prevent neural tube defects in foetuses (Ray et al., 2002) . Mass drug administration may also be done at the individual level, such as administration of topical antibiotics to all newborns to presumptively treat gonococcal ophthalmia and parenteral vitamin K to prevent neonatal haemorrhage (Zi-pursky, 1999) . In tropical countries where malaria is endemic all pregnant women are treated presumptively in the third trimester with antimalarial drugs to prevent the congenital transmission of malaria (WHO and Global Malaria Programme, 2012) . Mass screening programmes focus on identifying newborns with certain metabolic diseases that can be ameliorated if treated very early in life, such as congenital hypothyroidism and phenylkentonuria (Green et al., 2006) . In all these cases the state mandated diagnostics, preventive measures and therapeutics, either directly through law or by defi ning the standard of care, to protect unborn and newborn children. Public health laws permitting isolation and quarantine control the spread of communicable diseases at the cost of restricting individual liberties. Isolation refers to limiting the movement of a person with a communicable disease during the infectious period of that disease in order to prevent spreading of the disease. Quarantine, on the other hand, refers to limiting the movement of a person who has been exposed to (and may be infected with) a communicable disease during the potential incubation period of the disease. Quarantine and isolation were widely and eff ectively used to limit transmission and protect public health during the severe acute respiratory disease (SARS) outbreak in China in 2003 (Bondy et al., 2009 ) and in the recent Ebola virus outbreak in West Africa (CDC, 2015a).
CONCLUSIONS
In the United States of America there is a substantial corpus of state and federal law designed to protect public health from the spread of communicable diseases. Here we have reviewed mandatory school immunisation laws in California and how they have changed over time. Th ey are, however, but one example of how the duties of states to protect public health are translated into interventions. In order to limit the transmission of vaccine-preventable diseases, mandatory school immunisation laws must support the attainment and maintenance of herd immunity. Society has a vested interest in preventing the transmission of these diseases and the morbidity and mortality they cause. While waning immunity and vaccine failure do occur, epidemic disease transmission far too often is the result of failure to vaccinate rather than vaccine failure. In an ideal world, all infants and young children would be fully and promptly immunised without intervention from the state. Until that day dawns, school immunisation laws have proven to be an eff ective way to support vaccine coverage goals and to protect public health.
